¼¼°èÀÇ ÀǾàǰ ÷°¡Á¦ ½ÃÀå : Á¦Ç°º°, ±â´Éº°, Á¦Çüº°, ¿ëµµº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2025-2032³â)
Pharmaceutical Excipients Market, By Product, By Functionality, By Formulation, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
º¸°í¼ ÇÏÀ̶óÀÌÆ®
ÀǾàǰ ÷°¡Á¦ ½ÃÀå ±Ô¸ð´Â 2024³â 102¾ï 3,743¸¸ ´Þ·¯·Î 2025³âºÎÅÍ 2032³â±îÁö CAGR 6.96%·Î È®´ëµÉ Àü¸ÁÀÔ´Ï´Ù.
ÀǾàǰ ÷°¡Á¦ ½ÃÀå ¿ªÇÐ
»õ·Î¿î ¾à¹°Àü´Þ ½Ã½ºÅÛ°ú ¹ÙÀÌ¿ÀÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀǾàǰ ÷°¡Á¦ ½ÃÀåÀº Á¦¾à »ê¾÷ÀÇ È®´ë, ÀǾàǰ Á¦Á¦ÀÇ ¹ßÀü, »õ·Î¿î ¾à¹°Àü´Þ ½Ã½ºÅÛ µî ´Ù¾çÇÑ ¿äÀο¡ ÀÇÇØ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÀüÅëÀûÀÎ Á¦Á¦´Â Á¡Â÷ÀûÀ¸·Î Á¦¾î ¹æÃâ, ¼¹æÇü, Ç¥Àû ¾à¹°Àü´Þ°ú °°Àº »õ·Î¿î ¾à¹°Àü´Þ ½Ã½ºÅÛ(NDDS)À¸·Î ´ëüµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ã·´Ü ¾à¹°Àü´Þ ½Ã½ºÅÛÀº ÀûÀýÇÑ ¾à¹° ¹æÃâ, ¾ÈÁ¤¼º ¹× È¿´ÉÀ» º¸ÀåÇϱâ À§ÇØ Æ¯¼ö ºÎÇüÁ¦°¡ ÇÊ¿äÇÕ´Ï´Ù. °íºÐÀÚ ¹× ÁöÁú°ú °°Àº ºÎÇüÁ¦´Â ¾à¹°ÀÇ »ýü ÀÌ¿ë·üÀ» °³¼±Çϰí Åõ¿© Ƚ¼ö¸¦ ÁÙÀÌ´Â ¹æÃâ Á¦¾îÇü Á¦Á¦ °³¹ß¿¡ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ¶ÇÇÑ, Áß±¹, Àεµ, ºê¶óÁú°ú °°Àº ½ÅÈï ½ÃÀåÀº Á¦Á¶ ºñ¿ëÀÇ °¨¼Ò¿Í Á¤ºÎÀÇ ¿ìÈ£ÀûÀÎ Á¤Ã¥À¸·Î ÀÎÇØ ÀǾàǰ Á¦Á¶¿¡ ÀÖ¾î °·ÂÇÑ ¼ºÀåÀ» ¸ñ°ÝÇϰí ÀÖ½À´Ï´Ù.
ÀÚ´ç, Æ®·¹Çҷνº, ¸¸´ÏÅç°ú °°Àº ºÎÇüÁ¦´Â ¾ÈÁ¤¼ºÀ» À¯ÁöÇϱâ À§ÇØ µ¿°á°ÇÁ¶ »ý¹°ÇÐÀû Á¦Á¦¿¡ »ç¿ëµË´Ï´Ù. µû¶ó¼ ¹ÙÀÌ¿ÀÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ °è¼Ó Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ·¯ÇÑ º¹ÀâÇÑ Á¦Á¦¿¡ ¸Â°Ô Á¶Á¤µÈ Çõ½ÅÀûÀÎ ºÎÇüÁ¦ÀÇ Çʿ伺µµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹Ì±¹ ½ÄǰÀǾ౹(FDA), À¯·´ÀǾàǰû(EMA), ±¹Á¦ÀǾàǰ±ÔÁ¦Á¶ÈÀ§¿øÈ¸(ICH) µî ±ÔÁ¦ ±â°üÀº ÀǾàǰÀÇ Á¦Çü, ¾ÈÀü¼º, ǰÁú¿¡ ´ëÇÑ ¾ö°ÝÇÑ °¡À̵å¶óÀÎÀ» ½ÃÇàÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±âÁØÀ» ÃæÁ·Çϱâ À§ÇØ Á¦¾à»çµéÀº ÀǾàǰÀÇ ¾ÈÁ¤¼º°ú ¾ÈÀü¼ºÀ» Çâ»ó½ÃŰ´Â °íǰÁúÀÇ ÀûÇÕ¼º ³ôÀº ºÎÇüÁ¦¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.
ÀǾàǰ ÷°¡Á¦ ½ÃÀå : ÁÖ¿ä ÀλçÀÌÆ®
´ç»çÀÇ ¿¬±¸ ºÐ¼®°¡µéÀÇ ºÐ¼®¿¡ µû¸£¸é, ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2025-2032³â) µ¿¾È ¸Å³â ¾à 6.96%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Á¦Ç°º°·Î´Â À¯±âÈÇÐÁ¦Ç° ºÎ¹®ÀÌ Á¦³×¸¯ ÀǾàǰÀÇ ³ôÀº ¼ö¿ä·Î ÀÎÇØ 2024³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¾ú½À´Ï´Ù.
±â´Éº°·Î´Â °æ±¸¿ë °íü Á¦Á¦¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä·Î ÀÎÇØ 2024³â À±È°À¯ ¹× À±È°Á¦ ºÎ¹®ÀÌ ±â´É¼º ºÎ¹®À» ÁÖµµÇß½À´Ï´Ù.
Á¦Çüº°·Î´Â ĸ½¶Á¦, ¾×Á¦ÀÇ ³ôÀº ¼ö¿ä·Î ÀÎÇØ °æ±¸Á¦°¡ 2024³â ÁÖ¿ä Á¦ÇüÀ¸·Î ºÎ»óÇß½À´Ï´Ù.
¿ëµµº°·Î´Â ¹ÙÀÌ¿ÀÀǾàǰÀÇ ¾ÈÁ¤Á¦ ¼ö¿ä°¡ ³ô¾Æ 2024³â ¿ëµµº°·Î´Â ¾ÈÁ¤Á¦ ºÎ¹®ÀÌ 1À§¸¦ Â÷ÁöÇß½À´Ï´Ù.
Áö¿ªº°·Î´Â Á¦¾à±â¾÷ÀÌ ¸¹Àº ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ 2024³â ÁÖ¿ä ¼öÀÍ¿øÀÌ µÇ¾ú½À´Ï´Ù.
ÀǾàǰ ÷°¡Á¦ ½ÃÀå : ¼¼ºÐÈ ºÐ¼®
¼¼°è ÀǾàǰ ÷°¡Á¦ ½ÃÀåÀº Á¦Ç°, ±â´É, Á¦Çü, ¿ëµµ, Áö¿ªº°·Î ºÐ·ùµË´Ï´Ù.
½ÃÀåÀº Á¦Ç°º°·Î À¯±â³ó°ú ¹«±â·Î ³ª´¹´Ï´Ù. À¯±â ºÎ¹®ÀÌ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. »ý¹°ÇÐÀû Á¦Á¦, ½Å±Ô ¾à¹°Àü´Þ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
½ÃÀåÀº ±â´É¿¡ µû¶ó ÃæÁøÁ¦, °áÇÕÁ¦, ÄÚÆÃÁ¦, Âø»öÁ¦, ºØ±«Á¦, À±È°Á¦ ¹× À±È°À¯, ±âŸÀÇ 7°¡Áö ¹üÁÖ·Î ºÐ·ùµË´Ï´Ù. À±È°Á¦/À±È°Á¦´Â °æ±¸Á¦ ¼ö¿ä°¡ ³ô±â ¶§¹®¿¡ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
½ÃÀåÀº Á¦Çü¿¡ µû¶ó °æ±¸¿ë, ±¹¼Ò¿ë, ºñ°æ±¸¿ë, ±âŸ µî 4°¡Áö·Î ºÐ·ùµË´Ï´Ù. °¡Àå Å« ºñÁßÀ» Â÷ÁöÇÏ´Â °ÍÀº °æ±¸Á¦ÀÔ´Ï´Ù. ±¤¹üÀ§ÇÑ ¿ëµµ¿Í ´Ù¾çÇÑ Áúȯ¿¡ ´ëÇÑ È¿´ÉÀÌ ÀÌ ºÐ¾ßÀÇ ¼ö¿ä¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
½ÃÀåÀº ¿ëµµº°·Î ¾ÈÁ¤Á¦, ¹Ì°¢ ¸¶½ºÅ·, ±âŸÀÇ ¼¼ °¡Áö ¹üÁÖ·Î ºÐ·ùµË´Ï´Ù. ¿ëµµº°·Î´Â ¾ÈÁ¤Á¦°¡ °¡Àå ³ôÀº Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. Á¦³×¸¯ ÀǾàǰ »ý»ê, °íǰÁú ºÎÇüÁ¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀÌ °¡¼Óȵǰí ÀÖ½À´Ï´Ù.
ÀǾàǰ ÷°¡Á¦ ½ÃÀå : Áö¿ªº° ºÐ¼®
¼¼°è ÀǾàǰ ÷°¡Á¦ ½ÃÀåÀº ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡ ºÐÆ÷µÇ¾î ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â ¼¼°è ÀǾàǰ ÷°¡Á¦ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ¹Ì±¹Àº ¸¹Àº Á¦³×¸¯ ÀǾàǰ Á¦Á¶¾÷ü¿Í ¹ÙÀÌ¿À Á¦¾àȸ»ç¸¦ Æ÷ÇÔÇÑ °·ÂÇÑ Á¦¾à ºÎ¹®ÀÇ º»°ÅÁöÀÔ´Ï´Ù. ÀÌ´Â ºÎÇüÁ¦ ¼ö¿ä È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. À¯·´Àº Çõ½ÅÀû Á¦Á¦ÀÇ ÃÖÀü¼±¿¡ ÀÖÀ¸¸ç, ƯÈ÷ ¹ÙÀÌ¿ÀÀǾàǰ ¹× ¹é½Å ºÐ¾ß¿¡¼ Ư¼ö ºÎÇüÁ¦°¡ ÇÊ¿äÇÕ´Ï´Ù. À¯·´Àº °í·ÉȰ¡ ÁøÇàµÇ¸é¼ ¸¸¼ºÁúȯ¿¡ ´ëÀÀÇÏ´Â ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ƯÈ÷ °æ±¸Á¦ Á¦Çü¿¡¼ ÀǾàǰ ÷°¡Á¦ÀÇ ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ƯÈ÷ Àεµ¿Í Áß±¹¿¡¼ ÀǾàǰ À§Å¹»ý»êÀÇ °ÅÁ¡ÀÌ µÇ°í ÀÖ½À´Ï´Ù.
ÀǾàǰ ÷°¡Á¦ ½ÃÀå : °æÀï »óȲ
ÀǾàǰ ÷°¡Á¦ ½ÃÀåÀº °æÀïÀÌ Ä¡¿Çϸç, ¼ö¸¹Àº ¼¼°è ¹× Áö¿ª ±â¾÷µéÀÌ ´Ù¾çÇÑ Á¾·ùÀÇ ºÎÇüÁ¦¸¦ »ý»ê ¹× °ø±ÞÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÎÇüÁ¦´Â ÀǾàǰÀÇ Á¦ÇüÈ¿¡¼ Áß¿äÇÑ ¿ªÇÒÀ» Çϸç, ¾ÈÁ¤¼º°ú »ýü ÀÌ¿ë·üÀ» Çâ»ó½Ãŵ´Ï´Ù. ½ÃÀå ¾÷üµéÀº ¹æÃâ Á¶ÀýÁ¦, »ýü ÀÌ¿ë·ü Çâ»óÁ¦, ¾à¹° °¡¿ëÈÁ¦ µî ´Ù¾çÇÑ Á¦Çü¿¡ »ç¿ëµÇ´Â ºÎÇüÁ¦¸¦ Á¦°øÇÏ´Â µ¥ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. °¢ ȸ»ç´Â ¾à¹°ÀÇ ¼º´ÉÀ» Çâ»ó½ÃŰ´Â »õ·Î¿î ºÎÇüÁ¦¸¦ °³¹ßÇϱâ À§ÇÑ ¿¬±¸°³¹ß°ú ±â¼ú Çõ½Å¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¼¹æ¼º, ¹æÃâ Á¦¾î¼º, »ýü ÀÌ¿ë·üÀ» Çâ»ó½Ãų ¼ö ÀÖ´Â ºÎÇüÁ¦¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô½À´Ï´Ù. ȸ»ç´Â °·ÂÇÑ ¿¬±¸°³¹ß(R&D) ´É·ÂÀ» º¸À¯Çϰí ÀÖ¾î °í°´ ¸ÂÃãÇü ¼Ö·ç¼ÇÀ» Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÀǾàǰ ÷°¡Á¦ ½ÃÀå °³¿ä
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå ÀǾàǰ ÷°¡Á¦ÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
½ÃÀå ±âȸ
½ÃÀå Àü¸Á µ¿Çâ
Á¦4Àå ÀǾàǰ ÷°¡Á¦ ½ÃÀå : »ê¾÷ ºÐ¼®
PEST ºÐ¼®
Porter's Five Forces ºÐ¼®
½ÃÀå ¼ºÀå Àü¸Á : ¸ÅÇÎ
±ÔÁ¦ üÁ¦ ºÐ¼®
Á¦5Àå ÀǾàǰ ÷°¡Á¦ ½ÃÀå : ³ô¾ÆÁö´Â ÁöÁ¤ÇÐÀû ±äÀåÀÇ ¿µÇâ
COVID-19 ÆÒµ¥¹ÍÀÇ ¿µÇâ
·¯½Ã¾Æ¡¤¿ìÅ©¶óÀ̳ª ÀüÀïÀÇ ¿µÇâ
Áßµ¿ ºÐÀïÀÇ ¿µÇâ
Á¦6Àå ÀǾàǰ ÷°¡Á¦ ½ÃÀå »óȲ
ÀǾàǰ ÷°¡Á¦ ½ÃÀå Á¡À¯À² ºÐ¼®(2024³â)
ÁÖ¿ä Á¦Á¶¾÷üº° ³»¿ª µ¥ÀÌÅÍ
±âÁ¸ ±â¾÷ ºÐ¼®
½ÅÈï ±â¾÷ ºÐ¼®
Á¦7Àå ÀǾàǰ ÷°¡Á¦ ½ÃÀå : Á¦Ç°º°
°³¿ä
ºÎ¹®º° Á¡À¯À² ºÐ¼® : Á¦Ç°º°
À¯±â
¹«±â
Á¦8Àå ÀǾàǰ ÷°¡Á¦ ½ÃÀå : ±â´Éº°
°³¿ä
ºÎ¹®º° Á¡À¯À² ºÐ¼® : ±â´Éº°
ÇÊ·¯
¹ÙÀδõ
ÄÚÆÃÁ¦
Âø»öÁ¦
ºØ±«Á¦
ȰÅÃÁ¦¿Í À¯µ¿ÈÁ¦
±âŸ
Á¦9Àå ÀǾàǰ ÷°¡Á¦ ½ÃÀå : Á¦Çüº°
°³¿ä
ºÎ¹®º° Á¡À¯À² ºÐ¼® : Á¦Çüº°
°æ±¸
±¹¼Ò
ºñ°æ±¸
±âŸ
Á¦10Àå ÀǾàǰ ÷°¡Á¦ ½ÃÀå : ¿ëµµº°
°³¿ä
ºÎ¹®º° Á¡À¯À² ºÐ¼® : ¿ëµµº°
¾ÈÁ¤Á¦
¹Ì°¢ ¸¶½ºÅ·
±âŸ
Á¦11Àå ÀǾàǰ ÷°¡Á¦ ½ÃÀå : Áö¿ªº°
¼Ò°³
ºÏ¹Ì
°³¿ä
ºÏ¹ÌÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
¹Ì±¹
ij³ª´Ù
À¯·´
°³¿ä
À¯·´ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
µ¶ÀÏ
¿µ±¹
ÇÁ¶û½º
ÀÌÅ»¸®¾Æ
½ºÆäÀÎ
³×´ú¶õµå
½º¿þµ§
·¯½Ã¾Æ
Æú¶õµå
±âŸ
¾Æ½Ã¾ÆÅÂÆò¾ç(APAC)
°³¿ä
¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
Áß±¹
Àεµ
ÀϺ»
Çѱ¹
È£ÁÖ
Àεµ³×½Ã¾Æ
ű¹
Çʸ®ÇÉ
±âŸ
¶óƾ¾Æ¸Þ¸®Ä«(LATAM)
°³¿ä
¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
ºê¶óÁú
¸ß½ÃÄÚ
¾Æ¸£ÇîÆ¼³ª
ÄÝ·Òºñ¾Æ
±âŸ
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA)
°³¿ä
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
»ç¿ìµð¾Æ¶óºñ¾Æ
¾Æ¶ø¿¡¹Ì¸®Æ®
À̽º¶ó¿¤
ÅÍŰ
¾ËÁ¦¸®
ÀÌÁýÆ®
±âŸ
Á¦12Àå ÁÖ¿ä º¥´õ ºÐ¼® : ÀǾàǰ ÷°¡Á¦ ¾÷°è
°æÀï ´ë½Ãº¸µå
°æÀï º¥Ä¡¸¶Å©
°æÀï Æ÷Áö¼Å´×
±â¾÷ °³¿ä
Dow Inc.
Evonik Industries AG
BASF SE
Lubrizol Corporation
FMC Corporation
Roquette Freres
Sinopharm Group Co., Ltd.
Wacker Chemie AG
Shin-Etsu Chemical Co., Ltd.
InnoBio Limited
Ashland Global Holdings Inc.
Cargill, Inc.
JRS PHARMA GmbH &Co. KG
Mitsubishi Chemical Corporation
ARCH Chemicals, Inc.
Others
Á¦13Àå AnalystViewÀÇ Àü¹æÀ§Àû ºÐ¼®
ksm
REPORT HIGHLIGHT
Pharmaceutical Excipients Market size was valued at USD 10,237.43 Million in 2024, expanding to a CAGR of 6.96% from 2025 to 2032.
Pharmaceutical excipients are inactive substances formulated alongside the active pharmaceutical ingredient (API) in a drug. They serve various roles, such as aiding in drug delivery, enhancing stability, improving taste, and ensuring proper manufacturing.
Pharmaceutical Excipients Market- Market Dynamics
Rising demand for novel drugs delivery systems and biopharmaceuticals is expected to propel market demand
The pharmaceutical excipients market is experiencing significant growth, driven by various factors including the expansion of the pharmaceutical industry, advancements in drug formulations, and novel drug delivery systems. Traditional drug formulations are gradually being replaced by novel drug delivery systems (NDDS) such as controlled-release, sustained-release, and targeted drug delivery. These advanced drug delivery systems require specialized excipients to ensure proper drug release, stability, and effectiveness. Excipients like polymers and lipids are crucial in developing controlled-release formulations, which improve drug bioavailability and reduce dosing frequency. Additionally, emerging markets such as China, India, and Brazil are witnessing strong growth in pharmaceutical manufacturing due to lower production costs and favorable government policies.
Excipients such as sucrose, trehalose, and mannitol are used in freeze-dried biologics to maintain stability. Thus, as the demand for biopharmaceuticals continues to rise, so does the need for innovative excipients tailored for these complex formulations. Further, regulatory bodies such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and International Council for Harmonisation (ICH) enforce strict guidelines on drug formulation, safety, and quality. To meet these standards, pharmaceutical companies are focusing on high-quality, compliant excipients that enhance drug stability and safety.
Pharmaceutical Excipients Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.96% over the forecast period (2025-2032)
Based on Product segmentation, the organic chemicals segment was predicted to show maximum market share in the year 2024, due to high demand from generic drugs.
Based on Functionality segmentation, the lubricants & glidants segment was the leading Functionality segment in 2024, due to the high need of oral solid dosages.
Based on Formulation segmentation, the oral segment was the leading Formulation segment in 2024, owing to high demand from capsule, liquid formulations.
Based on Application segmentation, the stabilizers segment was the leading Application segment in 2024, owing to high need for stabilizers in biopharmaceuticals.
On the basis of the region, Asia Pacific was the leading revenue generator in 2024, owing to large presence of pharmaceutical companies.
Pharmaceutical Excipients Market- Segmentation Analysis:
The Global Pharmaceutical Excipients Market is segmented on the basis of Product, Functionality, Formulation, Application, and Region.
The market is divided into two categories based on Product: organic and inorganic. The organic segment dominates the market. The increasing demand for biological drugs, novel drug delivery is expected to boost market growth.
The market is divided into seven categories based on the Functionality: fillers, binders, coating agents, colorants, disintegrants, lubricants & glidants, and others. The lubricants & glidants segment is expected to hold the largest share due to the high demand from oral dosages.
The market is divided into four categories based on Formulation: oral, topical, parenteral, and others. The oral segment is expected to hold the largest share. The wider usage & its efficacy against different ailments is contributing to segment demand.
The market is divided into three categories based on Application: stabilizers, taste masking, and others. The stabilizers segment holds the highest share of the application segment. The increasing demand from generic drug production, high quality excipients is accelerating segment growth.
Pharmaceutical Excipients Market- Geographical Insights
Across the world, the Pharmaceutical Excipients market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America dominates the global pharmaceutical excipients market. The U.S. is home to a robust pharmaceutical sector, including many generic drug manufacturers and biopharmaceutical companies. This contributes to the growing demand for excipients. Europe is at the forefront of innovative drug formulations, particularly in the areas of biopharmaceuticals and vaccines, which require specialized excipients. With an aging population in Europe, there is a growing need for drugs that cater to chronic diseases, driving the demand for pharmaceutical excipients, especially in oral drug formulations. Asia-Pacific is becoming a hub for contract manufacturing of pharmaceuticals, particularly in India and China.
Pharmaceutical Excipients Market- Competitive Landscape:
The pharmaceutical excipients market is highly competitive, with numerous global and regional players engaged in the production and supply of a wide range of excipients. These excipients play a critical role in drug formulation, enhancing stability, bioavailability. Market players focus on offering excipients that are used in a wide variety of drug formulations, including controlled-release, bioavailability enhancers, and drug solubilizers. Companies are focusing on R&D and innovation to develop new excipients that improve drug performance. Excipients that can enable sustained-release, controlled-release, and bioavailability enhancement are in high demand. The company's strong research and development (R&D) capabilities allow it to offer tailored solutions for customers.
Recent Developments:
In 2023, BASF collaborated with Croda International Plc to develop and market new excipients aimed at improving drug delivery in oral and parenteral formulations.
In 2024, Roquette Freres has focused on developing plant-based excipients that cater to the growing consumer preference for natural ingredients.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET KEY PLAYERS
Dow Inc.
Evonik Industries AG
BASF SE
Lubrizol Corporation
FMC Corporation
Roquette Freres
Sinopharm Group Co., Ltd.
Wacker Chemie AG
Shin-Etsu Chemical Co., Ltd.
InnoBio Limited
Ashland Global Holdings Inc.
Cargill, Inc.
JRS PHARMA GmbH & Co. KG
Mitsubishi Chemical Corporation
ARCH Chemicals, Inc.
Others
GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019-2032
GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY- MARKET ANALYSIS, 2019-2032
Fillers
Binders
Coating agents
Colorants
Disintegrants
Lubricants & glidants
Others
GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION- MARKET ANALYSIS, 2019-2032
Oral
Topical
Parenteral
Others
GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032
Stabilizers
Taste masking
Others
GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA
Table of Contents
1. Pharmaceutical Excipients Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Pharmaceutical Excipients Market Snippet by Product
2.1.2. Pharmaceutical Excipients Market Snippet by Functionality
2.1.3. Pharmaceutical Excipients Market Snippet by Formulation
2.1.4. Pharmaceutical Excipients Market Snippet by Application
2.1.5. Pharmaceutical Excipients Market Snippet by Country
2.1.6. Pharmaceutical Excipients Market Snippet by Region
2.2. Competitive Insights
3. Pharmaceutical Excipients Key Market Trends
3.1. Pharmaceutical Excipients Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Pharmaceutical Excipients Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Pharmaceutical Excipients Market Opportunities
3.4. Pharmaceutical Excipients Market Future Trends
4. Pharmaceutical Excipients Industry Study
4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Pharmaceutical Excipients Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Pharmaceutical Excipients Market Landscape
6.1. Pharmaceutical Excipients Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players' Analysis
6.2.2. Emerging Players' Analysis
7. Pharmaceutical Excipients Market - By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
7.1.2. Organic
7.1.3. Inorganic
8. Pharmaceutical Excipients Market - By Functionality
8.1. Overview
8.1.1. Segment Share Analysis, By Functionality, 2024 & 2032 (%)
8.1.2. Fillers
8.1.3. Binders
8.1.4. Coating agents
8.1.5. Colorants
8.1.6. Disintegrants
8.1.7. Lubricants & glidants
8.1.8. Others
9. Pharmaceutical Excipients Market - By Formulation
9.1. Overview
9.1.1. Segment Share Analysis, By Formulation, 2024 & 2032 (%)
9.1.2. Oral
9.1.3. Topical
9.1.4. Parenteral
9.1.5. Others
10. Pharmaceutical Excipients Market - By Application
10.1. Overview
10.1.1. Segment Share Analysis, By Functionality, 2024 & 2032 (%)
10.1.2. Stabilizers
10.1.3. Taste masking
10.1.4. Others
11. Pharmaceutical Excipients Market- By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Pharmaceutical Excipients Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Pharmaceutical Excipients Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Pharmaceutical Excipients Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Pharmaceutical Excipients Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Pharmaceutical Excipients Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Pharmaceutical Excipients Industry
12.1. Competitive Dashboard
12.1.1. Competitive Benchmarking
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Dow Inc.
12.2.2. Evonik Industries AG
12.2.3. BASF SE
12.2.4. Lubrizol Corporation
12.2.5. FMC Corporation
12.2.6. Roquette Freres
12.2.7. Sinopharm Group Co., Ltd.
12.2.8. Wacker Chemie AG
12.2.9. Shin-Etsu Chemical Co., Ltd.
12.2.10. InnoBio Limited
12.2.11. Ashland Global Holdings Inc.
12.2.12. Cargill, Inc.
12.2.13. JRS PHARMA GmbH & Co. KG
12.2.14. Mitsubishi Chemical Corporation
12.2.15. ARCH Chemicals, Inc.
12.2.16. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us